Pfizer is set to meet with top U.S. health officials, including the Food and Drug Administration Monday to make the argument that a COVID-19 booster shot will be needed. Last week, Pfizer announced it will ask the FDA for emergency authorization for its third dose. The company says a third dose or booster may be…

Pfizer announced Thursday it will ask the Food and Drug Administration for emergency authorization of a third, or “booster” COVID-19 vaccine shot. Two doses of most vaccines are vital to develop antibodies against all versions of the coronavirus. But antibodies naturally wane over time, so studies also are underway to tell if and when boosters might…

WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. The Food and Drug Administration said it granted approval to the drug from Biogen based on results…

Moderna announced Tuesday it is filing for full U.S. Food and Drug Administration (FDA) approval of its COVID-19 vaccine. Right now, the vaccine is only authorized for emergency use. Full approval would allow Moderna to market the vaccine directly. Approval could also help curb vaccine hesitancy. Moderna said it will submit data to the FDA…